한글목차

세계 색전술 시장은 2025년에 24억 달러, 2032년에는 42억 8,000만 달러에 달할 것으로 예측되며, 2025-2032년간 연평균 8.6%의 성장률을 보일 것으로 예상됩니다.

그림. 2025년 지역별 색전술 시장 점유율(%)

색전술은 하나 또는 여러 개의 동맥이나 정맥을 막는 최소 침습적 시술입니다. 일반적으로 종양, 혈관 기형, 동맥류 등의 질환을 치료하는 데 사용됩니다. 색전술은 카테터라는 가느다란 관을 동맥이나 정맥에 삽입하여 순환계를 통해 표적 부위까지 통과시킵니다. 치료하는 병태에 따라 박리 가능한 코일, 알코올, 젤라틴 스펀지, 비드 등의 색전 물질을 카테터를 통해 주입하여 혈류를 차단합니다. 이 최첨단 치료법은 개복 수술의 대안으로 통증, 흉터, 회복 시간, 비용이 적게 드는 장점이 있습니다. 색전술은 다양한 치료 및 진단에 채택되고 있으며, 색전술 세계 시장 성장을 주도하고 있습니다.

시장 역학

세계 색전술 시장은 암, 혈관질환, 외상 등 다양한 대상 질환의 유병률 증가로 인해 괄목할 만한 성장을 보이고 있습니다. 이러한 병태에 취약한 노년층 증가가 시장 성장의 원동력이 되고 있습니다. 색전술 치료 장비의 기술적 진보, 생물학적 활성 색전제의 채택, 개복 수술보다 최소침습 수술에 대한 선호는 시장 진출기업에게 유리한 기회를 제공합니다. 그러나 신제품 승인에 대한 엄격한 규제 요건, 높은 비용, 일부 지역에서는 숙련된 전문가 부족이 시장 성장을 저해하는 요인으로 작용할 수 있습니다. 시장 진출기업들이 색전술에 대한 인식을 높이기 위한 다양한 노력과 첨단 색전술 재료의 개발은 가까운 시일 내에 이러한 장애요인을 극복하는 데 도움이 될 것으로 보입니다.

본 조사의 주요 특징

• 세계의 색전술 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 색전술 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 색전술 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 색전증 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map (COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 규제 시나리오
• 인수와 제휴 시나리오
• 자금조달과 투자
• PEST 분석
• Porter의 Five Forces 분석

제4장 세계의 색전술 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 이니셔티브
• 시장에 대한 COVID-19의 영향

제5장 세계의 색전술 시장, 제품 유형별, 2020-2032년(10억 달러)

• 서론
• 입자
• 방사선 색전술 스피어
• 약물 용출 비즈
• 마이크로스피어(또는 약제를 포함하지 않는 브랜드 비즈)
• PVA 입자(폴리비닐 알코올)
• 액체색전
• 플러그
• 코일

제6장 세계의 색전술 시장, 적응증별, 2020-2032년(10억 달러)

• 서론
• 출혈
• 양성 전립선 비대증(BPH)
• 자궁근종
• 종양(악성 종양, 간암 포함)
• 기형(AVM, AVF)
• 정맥 색전술
• 기타

제7장 세계의 색전술 시장, 최종사용자별, 2020-2032년(10억 달러)

• 서론
• 병원 클리닉
• 외래수술센터(ASC)
• 기타

제8장 세계의 색전술 시장, 지역별, 2020-2032년(10억 달러)

• 서론
• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 개요
  • Stryker Corporation
  • Medtronic plc
  • Boston Scientific Corporation
  • Johnson & Johnson(Cerenovis)
  • Terumo Corporation
  • Cook Medical
  • B. Braun Melsungen AG
  • Penumbra, Inc.
  • BTG plc
  • Merit Medical Systems
  • Pfizer Inc.
  • Abbott Laboratories
  • Acandis GmbH & Co. KG
  • Blockade Medical LLC
  • MicroPort Scientific Corporation
  • Kaneka Corporation
  • Galt Medical

제10장 애널리스트 추천 사항

• 융성과 쇠퇴
• Coherent Opportunity Map

제11장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Embolization Market is estimated to be valued at USD 2.40 Bn in 2025 and is expected to reach USD 4.28 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032.

Figure. Embolization Market Share (%), By Region 2025

Embolization is a minimally invasive procedure that blocks one or more arteries or veins. It is commonly used to treat medical conditions such as tumors, vascular malformations, and aneurysms. Embolization uses slender tubes called catheters, which are inserted into an artery or vein and then threaded through the circulatory system to the target site. Depending on the condition being treated, embolic materials such as detachable coils, alcohol, gelatin sponges, or beads are delivered through the catheter to block the blood flow. This cutting-edge therapy provides an alternative to open surgery and is associated with less pain, scarring, recovery time, and costs. Embolization is increasingly employed for various therapeutic and diagnostic procedures, thus, driving the global embolization market growth.

Market Dynamics:

Global embolization market is witnessing significant growth due to rising prevalence of various target conditions such as cancer, vascular diseases, and traumatic injuries. Growing geriatric population who are more prone to such conditions can drive the market growth. Technological advancements in embolization devices, introduction of bioactive embolization agents, and preference for minimally invasive procedures over open surgeries offers lucrative opportunities for market players. However, strict regulatory requirements for new product approval, high costs involved, and lack of skilled professionals in some regions can hamper the market growth. Various initiatives by market players to spread awareness about embolization therapy and development of advanced embolization materials can help overcome these restraints in the near future.

Key Features of the Study:

• This report provides in-depth analysis of the global embolization market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global embolization market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Boston Scientific Corp, Terumo Corporation, Medtronic plc, Stryker Corporation, and Abbott Laboratories.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global embolization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global embolization market.

Detailed Segmentation-

• By Product Type:
  • Particles
  • Radioembolization Spheres
  • Drug-Eluting Bead
  • Microspheres (or Blands beads, without drug)
  • PVA Particles (Polyvinyl Alcohol)
  • Liquid Embolic
  • Plugs
  • Coils
• By Indication
  • Hemorrhage/Bleeding
  • Benign Prostatic Hyperplasia (BPH)
  • Uterine Fibroid
  • Tumor (Malignant, including Liver Cancer)
  • Malformation (AVM, AVF)
  • Venous embolization
  • Others
• By End User
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Stryker Corporation
  • Medtronic plc
  • Boston Scientific Corporation
  • Johnson & Johnson (Cerenovis)
  • Terumo Corporation
  • Cook Medical
  • Braun Melsungen AG
  • Penumbra, Inc.
  • BTG plc
  • Merit Medical Systems
  • Pfizer Inc.
  • Abbott Laboratories
  • Acandis GmbH & Co. KG
  • Blockade Medical LLC
  • MicroPort Scientific Corporation
  • Kaneka Corporation
  • Galt Medical

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Indication
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Embolization Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Embolization Market, By Product Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Particles
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Radioembolization Spheres
• Drug-Eluting Bead
• Microspheres (or Blands beads, without drug)
• PVA particles (Polyvinyl Alcohol)
• Liquid Embolic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Plugs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Coils
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Embolization Market, By Indication, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hemorrhage/Bleeding
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Benign Prostatic Hyperplasia (BPH)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Uterine Fibroid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tumor (Malignant, including Liver Cancer)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Malformation (AVM, AVF)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Venous embolization
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Embolization Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals & Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Embolization Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson (Cerenovis)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cook Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • B. Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Penumbra, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BTG plc
  • Merit Medical Systems
  • Pfizer Inc.
  • Abbott Laboratories
  • Acandis GmbH & Co. KG
  • Blockade Medical LLC
  • MicroPort Scientific Corporation
  • Kaneka Corporation
  • Galt Medical

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact